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Abstract 
It has been suggested that the rate of queuine uptake ;nto cultured human fibroblasts i controlled by phosphorylation levels within the 
cell. We show that the uptake of queuine is stimulated by activators of protein kinase C (PKC) and inhibitors of protein phosphatase: 
while inhibitors of PKC. and down-regulation f PKC by chronic exposure to phorbol esters inhibit the uptake of queuine into cultured 
human fibroblasts. Activators of cAMP- and cGMP-dependent kinases exert no effect on the uptake of queuine into fibroblast cell 
cultures. These studies uggest that PKC directly supports the activity of the queuine uptake mechanism, and that protein phosphatase 
activity in the cell acts to reverse this. Regardless of the modulation of uptake rate. the level of intracellular queuine base saturates in 6 h. 
However. there is still an effect on the incorporation rate of queuine into tRNA of fibroblast cultures even after 24 h. We now show that 
the incorporation f queuine into tRNA in cultured human fibroblasts by tRNA-guanine ribosyltransferase (TGRase) is also stimulated by 
activators of PKC and inhibitors of protein phosphatase: while inhibitor.,+ of PKC decrease the activity of this enzyme. These studies 
suggest that PKC supports both the cellular transport of queuine and the activity of TGRase in cultured human fibroblasts, and that 
protein phosplzatasc activity in fi',;roblasts acts to reverse this phe~tomenon. A kinase-phosphatase control system, that is common to 
controlling both inm~cellular ~i,gnal transduction and many enzyme systems, appears to be controlling the availability of the queuine 
substrate and the mechanism lk)r its incorporation i to tRNA. Since hypomodification f transfer RNA with queuine is commonly 
observed iu undift~'rentiated, rapidly growing and neoplastically transformed cells, phosphorylation f the queuine modification system 
may be a critical regulatory mechanism for the modification of tRNA and subsequent control of cell growth and differentiation. 
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1. Introduction 
There are a large number of modified nucleosides found 
in tRNA molecules. Various individual modifications have 
been suggested to play important roles in molecular biol- 
ogy. One example is the queuosine modification of tRNA. 
The pro-formed base, queuine, is incorporated into tRNA 
as an irreversible post-transcriptional exchange for guanine 
in the first position of the anticodon of four fftNA isoac- 
ceptors (Asp. Ash. His and Tyr) to generate the nucleoside 
queuosine. The unique base exchange :eaction is catalyzed 
• Cnrrespondmg author, Fax: + I (804) 6834628. 
i Present address: Deparlmfmt of Internal Medicine. Spukane Internal 
Medicine. Spokane. WA 9922t). USA. 
2 Present address: Reagents Divisi~m. American Medical Laboratories. 
Fairfax. VA 22032. USA. 
0167-4889/96/$15.tx) ~ 1996 Elsevier Science B.V, All rights reserved 
SSDI 0167-4889(95)0n184-0 
by the enzyme tRNA-guanine ribosyltransferase (TGRase) 
(EC 2.4.2.29) [ I -4] .  
Research concerning the function of  qveuosine-mod- 
ified tRNA indicates it may be a controlling agent in the 
differentiation, development, and stress mana,~ement of
several cell types. Alterations in the levels of queuosine- 
modified tRNA have been observed uring differentiation 
and development for D. discoideum [5], plants [6], 
Drosophila [7-9], as well as development and aging in the 
rat [10]. Queuosine-modified tRNA in Escherichia coli 
protects the organism from stress induced by suboptimal 
growth conditions [1 I]. Queuosine-modified tRNA also is 
involved with lactate dellydrogenase and cytochrome b-559 
expression in mammalian systems, and therefore may be 
involved with management of oxidative stress in eukary- 
otic cells [12-14]. The presence of the queuine base has 
been proposed to have effects on controlling protein syn- 
thesis [!5], as well as aspects of protein phosphorylation 
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[15], and regulation of cell signaling by receptor tyrosine 
kinases [16]. Therefore. the queuine base and queuosine- 
modified tRNA appear to exert important controlling ef- 
fects on cellular physiology. 
Transfer RNA isolated from neoplastic tissues and 
transformed cell lines is hypomodified with queuosine to 
various degrees [2.17.18]. The degree of hypomodification 
is related to the severity or malignancy of disease in 
human !ymphomas, leukemias [19], lung cancers [20], and 
ovarian carcinomas [21]. Murine erythroleukemia cells are 
also typically queuosine-deficient, rhese cells can be forced 
to differentiate and have been saown to demonstrate a 
signifcant concurrent increase in tRNA queuosine levels 
[22,23]. The differentiation of these cells and the queuo- 
sine-level increase was blocked effectively by chronic 
treatment with the tumor promoter, 12-O-tetrade- 
canoylphorbol-13-acetate (TPA) [22]. These observatior.s 
suggest that hypomodification of tRNA with queuosine is 
related to growth enhancing or tumor promoting events. 
Chronic exposure of cultured normal human fibroblasts 
to phorbol- 12.13-didecanoate (PDD) induces a large inhi- 
bition of the queuosine modification of tRNA [24]. The 
decrease in queuosine content of tRNA precedes an in- 
crease in the population density of the fibroblast cultures. 
Concurrent addition of purified queuine effectively blocks 
the population density increase in fibroblast cultures chron- 
ically exposed to PDD. and maintains :.he queuo:dne level 
in those cells at near normal levels. These data imply that 
the free queuine base or the queuosine modification of 
tRNA is related to a controlled growth rate in normal 
human fibroblasts. 
Mammals are incapable of synthesizing their own 
queuine, and therefore must obtain it from their diet or gut 
flora [25,26]. Mammalian cells grown in culture obtain 
queuine from animal serum used to supplement their growth 
media [3,26]. This suggests that efficient cellular uptake of 
dietary queuine across the cell membrane is a prerequisite 
to the insertion of the base into tRNA by TGRase. It was 
demonstrated that cellular uptake of queuine may be sensi- 
tive to phorbol esters [27.28], and it was suggested that 
queuine uptake may be modulated by protein kinase C 
(PKC) [29]. Chronic exposure of cultured cells to pborbol 
esters has been shown to induce a proteo!ytic down-regu- 
lation of PKC and its activity [30]. Sittce we observed a
decrease in the level of queuosine-modified tRNA with 
chronic exposure of human fibroblasts to PDD [28]. it is 
proposed that the down-regulation of PKC activity levels 
in the cell cultures may be decreasing the activity of the 
mechanism for the formation of queuosine-modified tRNA. 
Evidence presented in this manuscript demonstrates that 
a PKC-protein phosphatase ystem is important tbr mainte- 
nance of queuine uptake rates. The phosphorylation level 
of the queuine uptake mechanism in cultured human fi- 
broblasts is proposed to modulate the baseline activity for 
queuine uptake into cultured normal human fbroblasts. 
However, the profound level of queuosine-hypomodifica- 
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tion obser',cd in tRNA after chronic exposure to PDD 
argues agaim, t substrate limitation as a sole mediating 
influence, since queuine still gets into the cell to a sat- 
urable level by 6 h. albeit at a modestly reduced rate. Our 
results suggest hat a PKC-protein phosphatase ystem is 
also important for maintenance of the TGRase activity 
level in cultured cells. The level of phosphorylation of
both the queuine uptake mechanism and the incorporation 
enzyme (TGRase) in cultured human fibroblasts modulates 
the baseline activity for the formation of the queuosine 
modification in the anticodon of four tRNAs. 
2. Materials and methoqJs 
2. I. Cell culture 
Cell culture:, were established and maintained in neona- 
tal calf serum supplemented minimum essential media 
(GIBCO, Grand Island NY) as previously described [2-4,]. 
Queuine-deficient fbroblast cultures for the queuine incor- 
poration studies were generated by growing the cells in 
media supplemented with 10% charcoal stripped calf serum 
[24], for at least three passages before the studies were 
initiated. 
The addition of a radiolabelled analog of queuine. 
tri-tritiated dihydr,~ueuine (rQT3), to cell cultures was 
employed to monitor cellular uptake of this base and its 
incorporation i to tRNA. This agent was obtained as a gift 
from Dr. Ronald W. Trewyn (Kansas State University). 
The rQT~ substrate was prepared by dissolving lyophilized 
rQT 3 in water to yield a stock concentration of I mM with 
a specific activity of 0.t9 btCi//.tg and stored at -20°C. 
cGMP- and cAMP-dependent kinase, and PKC activa- 
tors were obtained from Sigma Chemicals (St. Louis. MO). 
The cGMP and cAMP analogues (dibutyryl and 8-brom¢,; 
were applied to cell cultures at a concentration of 10/,tM. 
12-tetradecanoyl phorbol- 13-acetate (TPA) and phorbol- 
12,13-didecanoate (PDD) were used at concentrations of
20 riM. The PKC inhibitors phingosine (used at 20 /.tM), 
staurosporine (used at 100 riM), and calpbostin C (used at 
100 nM) were purchased from Biomol Research Laborato- 
ries of Plymouth Meeting, PA. The PKC inhibitor H-7 
(I-(5-isoquinoline sulfonyl)-2-methyl piperazine dihydro- 
chloride) (utilized at 10 /.tM) was obtained from Seika- 
gaku America (St. Petersburg, FL). The protein phos- 
phatase inhibitors okadaic acid and calyculin A (utilized at 
varying nM concentrations) were purchased from Biomol 
Research Laboratories. All culture work was pertbrmed in 
sterile polystyrene plasticware from Coming. 
2.2. Assay f i ,r rQ'~r~ uptake imo cells 
Fibroblasts were subcultured into 35-ram dishes at a 
density of 4 × 10 ~ cells/ml in a final volume of 2 ml of 
media containing 10% serum. When the cells reached 
R.C. Morris et al. / Biochimica el Biol~hysica Acta 1311 (1996) 124-132 
confluence, the media was decanted and I ml of media 
supplemented with 10% calf serum and 100 nM rQT 3 
(0.10 ,ttCi) was added to the cultures. Uptake of rQT 3 into 
untreated control cultures was compared to cultures treated 
with kinase or protein phosphatase modulating agents at 
concentrations as stated above. For short-term exposure 
studies, PKC and protein phosphatase inhibition agents 
were added to the culture at the same time as the rQT 3 
substrate. For chronic exposure stt~dic:~, the agents were 
introduced to the cell growth media and exposed to the 
cells for seven days prior to the introduction of  rQT 3. 
Incubations for rQT 3 uptake analysis were conducted at 
37°C for up to 4 h and terminated by rinsing the cell 
monolayer four times with 5 ml of ice-cold phosphate- 
buffered saline, followed by cell lysis with 1.0 ml of 95% 
ethanol for 5 min. The lysate was aspirated and radioactiv- 
ity determined by liquid scintillation. The level of radioac- 
tivity in the cell lysate is reflective of  rQT 3 uptake into the 
cultured cells. 
2.3. Assay fo r  rQT~ #tcorporation into tRNA 
Fibroblasts were subcultured into 35-mm dishes at a 
density of 4 × l0 "~ ce l ls /ml  in a final volume of 2 ml of 
media containing 10% charcoal stripped calf serum. When 
the cells reached confluence, the media was decanted and 
I m! of media supplemented with 10% charcoal stripped 
calf serum and 100 nM rQT 3 (0.10/xCi)  was added to the 
cultures. Incorporation of rQT3 into the acid precipitable 
fraction (tRNA) of control cultures was compared to cul- 
tures treated with kinase activators or inhibitors and pro- 
tein phosphatase inhibitors. PKC and protein phosphatase 
inhil,itors were added to the cultures at the same time as 
rQT 3 for short-term studies, or 7 days prior to the addition 
of rQT 3 for chronic exposure studies. Incubations for rQT 3 
incorporation analysis were conducted at 37°C for timed 
intervals of up to 12 h. Incubations were terminated by 
rinsing the cell monolayer four times with 5 ml of ice-cold 
phosphate-buffered saline, followed by disruption of the 
cells with 0.5 ml of  lysis buffer (10 mM Tris (pH 7.5), 
0.01% SDS, 0.01% Triton X-100) for I0 min at room 
temperature. The lysate was transferred to a small test tube 
and treated with 0.25 ml of ice-cold 30% trichloroacetic 
~, :id (TCA). The lysate was placed on ice for 10 min and 
the resulting precipitate was collected by vacuum aspira- 
tion through GFA 2.4 cm glass fiber filter disks. Each disk 
was thoroughly rinsed with 40 ml of  ice-cold 5% TCA and 
a final rinse of 5 ml ice-cold 95% ethanol. The filters were 
analyzed for bound radioactivity by liquid scintillation, 
The level of radioactivity on the filter disks was reflective 
of  rQT 3 incorporation into the acid precipitable fraction 
(tRNA) from cultured fibroblast cells. 
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Fig. I. The effect of protein kinase and protein phosphatase modulators on qur:uine uptake in human fibroblast:,. The "untreated' bar represents rQT~ 
uptake in untreated control cultures, with experimental s mples representing rQT 3 uptake in cultures exposed to various kinase and phosphatase modulators 
for 3 b. The cultures were treated with modulators at the following concentrations: 10p.M dibutyryl-cGMP, 8-bromo-cGMP. dibutyryl-cAMP and 
8-bromo-CAMP. 20 nM TPA and PDD. and 10 nM okadaic acid, I nM calyculin A, 100 nM calpbostin C. 20 p,M sphingosine. 100 nM staurosporine and 
10/zM H-7. respectively. The uptake of the radiolabelled queuine in all cultures (4 × 105 cells) was measured after a 3-h incubation with 100 nM rQT~ 
and modulators at 37°C. These values were normalized tonumber of pmol rQT~ taken up by 105 cells, and convened to percentage uptake with the control 
culture value (5.5 4- 0.3 pmol/lO 5cells) serving as 100e/L Deviation bars indicated represent the standard deviation with n = 6. 
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3. Resu l t s  
3,1. Regulation of  the queuine uptake mechanism 
Due to the reported sensitivity o f  queuine uptake to 
phorbol esters [28.29], it was suggested that this system 
might be activated by PKC-catalyzed phosphorylatiotL In 
this study, several kinase and phosphatase modulators were 
used to identify the specific kinase and phosphatase fami- 
lies involved in the regulation of  the queuosine modifica- 
tion system. Activators for cAMP-dependent protein ki- 
nase (butyryl -cAMP and 8-bromo-cAMP),  cGMP-depen- 
dant protein kinase (butyryl -cGMP and 8-bromo-cGMP).  
and PKC (TPA and PDD) were employed to identify the 
participating kinase family. PKC activators (TPA and PDD) 
and inhibitors (calphostin C, sphingosioe, staaurosporine, 
and H-7). as well as phosphatase inhibitors (okadaic acid 
and calyculin A) were studied to establish and verify 
phosphorylation as the control mechanism for queuine 
uptake. 
Cultured human flbroblasts (passages 3 -5 )  were ex- 
posed to these agents to discern influences on rQT 3 uptake 
after a 3-h incubation (Fig. 1). The agents that are reported 
to stimulate the cAMP-  or cGMP-dependent kinase sys- 
tems had no effect on the rate of  rQT 3 uptake. However,  
stimulators of  PKC increased the rate of rQT 3 uptake by 
50% when compared to untreated controls. By contrast, 
cellular exposure to inhibitors of PKC all decreased the 
rate of  rQT~ uptake. Additional fibroblast cultures were 
exposed to the protein phosphatase inhibitors in order to 
maintain higher protein phosphorylation levels within the 
cell. These cultures showed a similar increase in queuine 
11 
5 5 
3 ~J_<__z - -  . . . .  ;~ 3 
l 1 
G: i 
1 2 3 4 1 2 3 4 
Time (hours) Time (hours) 
l° 9 C / 
2 ~ ~ 
1 
O: 
4 1 2 3 
Time (hours) 
Fig. 2. The effect of protein kinase C and protein phosphatase modulators on queuine uptake in short-term and chronic exposure studies in human 
libroblasts. Graph 2a displays th:' uptake of rQT. during short-term exposure of cultures to protein kinase C inhibitors. The top line ( + ) represents rQT~ 
uptake in untreated control cuht~res, with the lower two lines representing cultures treated with 100 nM staurosporine ( I ) .  and 100 nM calphostin C (0).  
respectively. Graph 2h illustrates the uptake of rQT~ during short-term exposure of cultures to protein kinase C activators and protein phosphatase 
inhihitors. The bottom line (+)  represents an rQT 3 uptake in untreated control cultures, with the upper lines representing cultures treated with l0 nM 
okadaic acid (O), 1 nM calycufin A (O). and 20 nM TPA ( C] l. respectively. In these showterm exposure studies, modulators were added to cultures at 
time 0. Graph 2c shows the uptake of rQT~ during chronic exposure of cuhures to the modulators. The traces represent rQT~ uptake in untreated control 
cultures (+). and those pre-exposed fer 7 days to 20 nMTF'A (C2). I nM okadaic acid (O). and 10 nM staurosporine (•) .  The uptake of the radiolabelled 
queuine in all cultures was measured after a 37°C incubation with 100 nM rQT~ at O. I. 2. 3 and 4 h. These values were then normalized to number of 
pmot rQT 3 taken up by i0 "~ cells. Deviation bars indicated represent the standard eviation with n = 4. 
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uptake when compared to those treated with PKC activa- 
tors. further suggesting that phosphorylation is involved in 
the regulation of queuine lransport. 
Parallel time course studies of rQY~ uptake with short- 
term treatment to staurosporine, calphostin C. TPA. caly- 
culin A. and okadaic acid were performed and compared to 
the rQT.~ uptake rate in control cells at hourly intervals 
over 4 h. Exposure to the PKC inhibitors resulted in a 
decrease in the uptake rate for rQT s as compared to 
untreated control fibroblast cultures (Fig. 2a). The PKC 
activator (TPA) nearly doubled the rate of rQT~ uptake. 
while the protein phosphatase inhibitors also stimulated the 
rQT 3 uptake rate (Fig. 2b). This further indicates that 
queuine uptake efficiency is linked to protein phosphoryla- 
tion levels. 
Fibroblast cultures were pre-treated for 7 days with 
TPA. staurosporine, and okadaic acid in order to measure 
effects of long-term exposure to these modulators on 
queuine uptake (Fig. 2c). This is particularly revealing 
since chronic exposure to TPA results in proteolytic 
down-regulation f PKC activity [30]. As expected, expo- 
sures to the PKC inhibitor significantly decreased the 
uptake of queuine at 3 h of exposure to rQT 3. while 
treatment with low levels of the phosphatase iuhibitor 
induced a two-fold increase in rQTs uptake. Furthermore. 
chronic exposure to TPA resulted in an inhibition of rQTs 
uptake rate when compared with untreated control cultures. 
This is a reversal of the effect observed in Fig. 2b with 
short-term exposure to TPA. and supports the PKC modu- 
lation scheme for queuine uptake based on the idiosyn- 
crasy of differential effects on PKC with short-term vs. 
chronic exposure to phorbol esters. 
The relatively high concentrations of the protein phos- 
phatase inhibitors used in the short-term exposure study 
was cause for concern given their reported toxicity levels 
[31-33]. A range of concentrations of calyculin A and 
okadaic acid were studied to analyze their effects on the 
3-h time point for rQT 3 uptake relative to untreated control 
fibroblast cultures (Fig. 3). These studies were performed 
for both short-term (simultaneous exposure to inhibitor and 
rQT 3) and for chronic exposure to the inhibitors (pre-treat- 
merit: 7 days prior to addition of rQT3). 
Concentrations of okadaic acid in excess of 100 nM 
proved to be cytotoxic for the 3-h short-term exposure 
studies. However, increasing concentrations of okadaic 
acid from 5 to 100 nM demonstrated progressively increas- 
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Fig. 3. Tile effect on queuine uptake oI" short-term and chronic exposure 1o protein phospn*atase inhibitors in human fibroblasts. These bar graphs represent 
the effects of exposure ofvarying concentrations {,f okadaic acid (graphs a and b) and calyculin A (graphs c and d) on rQT~ uptake in cultures. Short-term 
expo,ure studies (graphs aand c) were conducted with exposure of cells to the modulator attime O. Chronic exposure studies (graphs b and d) were 
conducted with pre-treatmcnt of cultures tor 7 days prior to time 0. The uptake of the radiolabelled queuine in all cultures (4 × 10 :~ cells) was measured 
after a 3-h incubati,m with I(~) nM rQT~ at 37~C. Thc,e values were normalized tonuml',er of pmol rQT~ taken up by 10 s cells, and convened 1o 
percentage uptake x~ith the control cuhurc value (5.5 _+ O.3 pmol/lO ~ cells) serving as 100%. Deviation bars indicated represent the standard deviation 
wilh n = 6. 
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ing rQT 3 uptake (Fig. 3a). Similar trends were observed in 
studies of chronic exposure to this phosphatase inhibitor 
(Fig. 3b). Increasing concentrations of okadaic acid from I 
to 10 nM demonstrated progressively increasing rQT3 up- 
take rates, while concentrations over 10 nM were cytotoxic 
to the fibroblast cultures. Comparable results were seen 
with studies using the protein phosphatase inhibitor caly- 
culin A. However, the fibroblast cultures were much more 
sensitive to this compound. Exposure for 3 h to 1 nM 
calyculin A effectively increased the rate of rQT~ uptake 
(Fig. 3c). For chronic exposure (7 day pre-treatment), 0.2 
nM calyculin A demonstrated quivalent maximal induc- 
tion of rOT3 uptake rate (Fig. 3d). Concentrations above 
these levels were cytotoxic in both short-term and chronic 
exposure studies, respectively. 
it has been reported that calyculin A is a more effective 
inhibitor of protein phosphatase 1 than okadaic acid. In one 
study, IC50 values of approx. 50 nM for okadaic acid and 
0.3 nM for calyculin A were reported for muscle phos- 
phatase I [31]. Based on the reported sensitivity of protein 
phosphatases type I and 1I to okadaic acid and calyculin A 
with pre-treatment exposure [31-33], our data suggest that 
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protein phosphatases of the type I group are participating 
in the modulation of rQT 3 uptake in human fibroblasls. 
3.2. Regulation t~f the queuine incorporatirm rnechanisrn 
Ahhough tl-e rate of uptake can be modulated, it was 
observed that maximal uptake of the queuine base to a 
saturating level occurs in 6 h (unpublished data). After this 
point, uptake and efflux are balanced [27]. Thus, the 
modulation of the uptake mechanism ight not be solely 
responsible tk)~ the dramatic queuosine-modification defi- 
ciency seen in neoplastic transformation and progression 
of cancer cells to metastasis. Thus, the queuine incorpora- 
tion mechanism (TGRase) was studied to determine if 
PKC acts in a dual role in modulating both components of
the queuine modification system. 
First, cultured human fibroblasts (passages 3-5)  were 
exposed to dibutyryl and 8-bromo analogs of cAMP and 
cGMP. as well as TPA, PDD, calphostin C. sphingosine, 
staurosporine. H-7. okadaic acid or calyculin A for up to 
12 h in order to determine ffects on the incorporation of 
rQT, into tRNA by TGRase (Fig. 4). The queuine incorpo- 
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Fig. 4. The effect of protein kinase and protein phosphatasc modulators onqueuine incorporation into IRNA in human fihroblasts. The top four bars 
represent  rQT~ incorporation into the acid-precipitable fraction (tRNA) of control cultures. The 'untreated" bar represents rQT; incorporation in untreated 
'nornPA' cultures and is, therefore, used as a point of retetence for 100~ ,QTt incorporalion. The "Q -cells" bar represents rQT~ incorporation in 
queuine-defieient cells that were preincubated with charcoal-stripped media for three pa,~ages. Therefore. this represents the maximal limit for the 
incorporation f rQT 3. The 'Q + cells" bar represent~ rQT, incorporation in queuine-samrated cells that ~ere preincubated with normal media plus an 
additional 0.10 A2m )queuine for three passages. Thus, this sets the minimal limit for incorp~,ration. The last control bar represents rQT~ incorporation in 
cells treated with 10 ~tM 7-methylguanine. a competitive inhibitor for the incorporation e zyme TGRase. This also helps to verify the minimal level of 
incorporation activity in this study. Remaining bars represent rQT~ incorporation into the tRNA of cultures exposed to various kinase and phosphatase 
modulators for 8 h at concentrations f 10 /xM for dibutyryl-cGMP. 8-bromo-cGMP. l0 .v.M dibut}ryl-cAMP and 8-bromo-cAMP. 20 nM for TPA and 
PDD, and l0 nM okadaic acid. 0.2 nM calyeulin A. 100 nM calphostin C. 20 ~tM sphingosine. 100 nM staurosporine and 10 pM H-7. respecti~t ly. The 
incorporation f radiolabelled queuine into tRNA in all cultures (4 × l0 ~ cells) was measured after a 37°C incubation with 100 nM rQTt and modulators at 
8 h. These values were normalized tonumber of pmol rQT~ incorporated into the acid-precipitable fraction of l0 ~ cells. The "untreated" bar represents 
rQT3 incorporation in untreated 'normal' cultures (measured at 3.0 _+ 1).2 pmol/10 ~ cell',), and ~a> used as the basis for the conversion fexperimental 
cultures' values into percentage. Deviation bars indicated represent the standard deviation ~ith n = b. 
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ration rates of cells exposed to these modulators were 
compared to an untreated control culture and three addi- 
tional control (positive and negative) cultures. These addi- 
tional control fibroblast cultures were utilized to establish 
both the maximum and min imum incorporation linrits for 
comparison to the experimental sample 
Fibroblasts deficient in queuosine-modif ied tRNA were 
established in queuine-deficient media supplemented with 
charcoal-stripped serum. Cells grown under these condi- 
tions for three passages are completely deficient in queue- 
sine-modified tRNA (unpublished data). Queuosine-defi- 
cient tRNA cultures were used as substrate targets for 
demonstrating the maximal incorporation rate of rQT 3 into 
tRNA by TGRase (positive control). These cells demon- 
strated a nearly two-fold increase in rQT 3 incorporation 
rate when compared to normal serum-supplemented con- 
trois. The slower rate of  incorporation in serum-supple- 
mented control cells is likely due to partial queuosine- 
modification of  the existing tRNA population in the cell. 
Two negative control cultures were grown in 10% serum- 
supplemented media. One culture was treated with addi- 
tional 100 nM queuine and the other was treated with 10 
/.tM 7-methylguanine. Addition of  excess queuine com- 
pletely and irreversibly saturates the cell 's tRNA with 
queuosine and eliminates the cel l 's tRNA as a substrate for 
rQT 3 incorporation. 7-Meiltylg,,anine is a competit ive in- 
hibitor of TGRase and blocks the ability of  TGRase to 
incorporate rQT 3 into tRNA at concentrations used here 
[34]. These two cultures both represent he background 
levels of non-specific rQT3 association to the acid precipi- 
table fraction of  solubilized cell cultures, which is ex- 
pected with the absence of  TGRase activity. 
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Fig. 5. The effect of protein kinase C and protein phosphatase modulators on queuine incorporation i to tRNA in human fibroblasts. Graph 5a) displays the 
incorporation of rQT 3 into IRNA during short-term exposure of cultures to protein kinase C inhibitors. The top line ( + ) represents incorporation of rQT 3 
into acid-precipitable fractions of untreated control cultures: the lower line~ represent values for culture!; treated with 100 nM calphostin C (O), 100 nM 
staurosporine (•) .  and 20 /.tM sphingosinc (• ) .  respectively. Graph 5b illustrates the incorporation of rQT 3 into tRNA during short-term exposure of 
cultures to protein kinase C activators and protein phosphatase inhibitors. The bottom line ( + ) represents incorporation of rQT 3 into tRNA of untreated 
comrol cultures: the upper lines represent cultures treated with 10 nM oki~daic acid ('¢'), 20 nM TPA (O), and 0.2 nM calyculin A (O). respectively. In
these short-term exposure studies, modulators were added to cultures at time 0. Graph 5c show:~ the incorporation of rQT:~ into tRNA during chronic 
exposure of cultures to the modulators. The traces represent the rate of rQT~ incorporation i to the tRNA of untreated control cultures t+ ) and those 
pre-treated for 7 days to 20 nM TPA ( C3 ). 10 nM okaduic acid (¢'), and 100 nM staurosporine (• ) .  The incorporation of radiolabelled queuine into tRNA 
in all cultures (4 × 105 cells) was measured after a 37°C incubation with 100 nM rQT at O. 3.6. 9 and 12 h. These values were normalized to number of 
pmol rQT~ incorporated into the acid-precipitable fraction of 105 cells. Deviation bars indicated represent the standard eviation with n = 4. 
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Cell cultures treated with agents that increase the acliv- 
ity of cAMP- and cGMP-dependent kinases appear to 
have no effect on the incorporation rate of rQT 3 (Fig. 4). 
However, PKC activa',ors and phosphatase inhibitors in- 
crease the incorporation of rQT 3 toward that observed in 
totally queuosine-deficient cells. While cells treated with 
inhibitors of PKC reduce the incorporation of rQT~ to a 
t, aseline level just above that of non-specific binding. This 
further demonstrates that PKC-catalyzed phosphorylation 
is important in cegulation of TGRase activity, thus the 
formation of the queuosine modification of tRNA. 
Next, a 12-h time course for rQT 3 incorporation into 
tRNA of queuosine-deficient tRNA fibroblast cultures was 
performed in cells grown for three passages in 10c~ char- 
coal-stripped serum (queuine-free) supplemented media 
(Fig. 5a,b). In short-term exposure studies, rQT 3 and vari- 
ous modulating agents (staurosporine, sphingosine, 
calphostin C, TPA, okadaic acid and calyculin A) were 
simultaneously added to parallel cultures. Then. these were 
analyzed for rQT 3 incorporation i to tRNA at 4-h intervals 
for 12 h. lnhibitors of PKC decreased the rate of rQT 3 
incorporation i to tRNA to a baseline level as compared to 
untreated controls (Fig. 5a). The protein kinase activator 
and phosphatase inhibitor, when added to cell cultures at 
the same time as rQT 3, both increased the rQT3 incorpora- 
tion rates when compared to untreated control cells (Fig. 
5b). Queuosine-deficient cells pre-treated with various 
agents for 7 days were studied for rQT 3 incorporation rates 
into tRNA over a 12-h time course (Fig. 5c). Chronic 
exposure to TPA, which induces a proteolytic down-regu- 
lation of PKC [30], resulted in a decrease in rQT 3 incorpo- 
ration into tRNA. However, treatment with staurosporine 
was more effective at inhibiting the rate of rQT 3 incorpora- 
tion in cell cultures. It is both possible and likely that 
residual PKC activity may still be present in the cells 
chronically exposed to TPA. 
Chronic pre-treatment of these cells for 7 days with 
okadaic acid showed rQT 3 incorporation levels lower titan 
that of the control. Since this treatment maintains the 
phosphorylation level in the cell, the activity of TGRase 
should be enhanced ,Jring this preparative step. TGRase 
would effectively recycle queuine from tRNA turnover and 
incorporate it into new transcripts of tRNA. At the time of 
the rQT 3 addition, the cognate tRNA would be saturated 
with the queuosine modification and would no longer be 
used as a substrate for incoming rQT 3 due to the irre- 
versible nature of the queuine incorporation reaction. 
Therefore, chronic exposure to okadaic acid should actu- 
ally decrease the rate of rQT 3 incorporation i to tRNA as 
compared to control cultures, and this is indeed the case 
(Fig. 5c). 
4. Discussion 
The uptake of queuine into human fibroblasts appears to 
be modulated by phosphorylation. Activators of cAMP and 
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cGMP dependeot kinases have no effect on rQT 3 uptake. 
However, increasing PKC activity with phorbol ester treat- 
ment elevates the rate of rQT 3 uptake. Conversely, chronic 
exposure of TPA to fibroblast cultures, which is known to 
down-regulate PKC activity, decreases rQT 3 uptake. A 
spectrum of protein kinase inhibitors, with various speci- 
ficities to PKC. all inhibit rQT 3 uptake into fibroblast 
cultures in concentration ranges reported to be most spe- 
cific for PKC. These results make a strong case for the role 
of PKC in enhancing the uptake rate of queuine into 
fibroblast cultures. 
The inhibition of protein phosphatases byboth okadaic 
acid and calyculin A also induces an increase in the uptake 
of rQT,. These results indicate that maintenance ofprotein 
phosphorylation is important o maximize the rate of 
queuine uptake. Due to the concentrations of the two 
phosphatase inhibitors involved, it is likely that protein 
phosphatases of type ! are down-regulating queuine uptake 
activity by removing a phosphate group from the queuine- 
specific membrane transporter. This analysis is based on 
reported sensitivity of protein phosphatases type 1 and It to 
okadaic acid and calyculin A [31-33]. 
TGRase activity in cultured human fibroblasts also 
appears to be modulated by PKC and protein phosphatase 
activity. Activators of cAMP- and cGMP-dependent ki- 
nases have no effect on rQT 3 incorporation. However, 
activators of PKC and inhibitors of protein phosphatase 
both increase TGRase incorporation rates above a baseline 
incorporation level, while inhibitors of PKC decrease in- 
corporation rates of rQT 3 to the baseline level. Chronic 
exposure to TPA, which is known to induce a proteolytic 
down-regulation of PKC, also decreases rQT 3 incorpora- 
tion into fibroblast tRNA when compared to untreated 
controls. These results make a strong case for the role of 
PKC in enhancing the incorporation rate of queuine into 
tRNA in fibroblast cultures. Furthermore, supporting evi- 
dence recently published by this laboratory demonstrates 
direct phosphorylation and activation of purified rat liver 
TGRase by PKC in vitro [35]. This indicates that control of 
TGRase activity by phosphorylation may be a universal 
mammalian phenomenon. 
We propose that PKC and protein phosphatase are 
important modulators of both queuine uptake and incorpo- 
ration into tRNA in cultured human fibroblasts. These are 
likely to be independently regulated sites for PKC due to 
(I) the ability of the uptake mechanism to fully saturate 
the cell with queuine in 6 h despite down-regulation by 
dephosphorylation, (2) the observation of the modulation 
of TGRase activity up to 24 h, and (3) the in vitro 
evidence that shows direct phosphorylation and regulation 
of rat liver TGRase activity by PKC [35]. 
PKC activity stimulates queuine uptake and incorpora- 
tion rates, while competing phosphatase activity reduces 
these to a baseline level. Kinase-phosphatase control sys- 
tems are important components of the cell's signal trans- 
duction system, and are known to be critical components 
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involved with differentiation, control of  cell growth and 
neoplastic translormation. This work ties an important 
signal transduction etwork to mechanisms responsible for 
tRNA modif ication with qucuinc. Alterations in the signal 
transduction system can effect both the availabil ity of  
queuine base and the activity of TGRase  which can poten- 
tially lead to the queuosine-hypomodif icat ion f  tRNA 
commonly  observed in netJplastically transformed and un- 
differentiated cells. 
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